MiMedx Group, Inc. MDXG
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
MiMedx Group, Inc. is a leading biopharmaceutical company specializing in regenerative medicine. The company's primary focus is on the development and commercialization of innovative bioimplants derived from human placental tissues. MiMedx's products are designed to enhance healing by leveraging the innate properties o…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees808
TickerMDXG
Statistics
Market Cap$535.4M
Revenue (TTM)$418.6M
Net Income$48.6M
Net Margin11.6%
EPS$0.32
P/E18.45
P/S1.41
P/B2.13
EV/EBITDA7.56
ROE13.8%
Dividend Yield—
Price$3.60
Data: Twelve Data · Revenue = mcap / P/S